Biotech · Private company
Bold Therapeutics, Inc.
Track this companyFree. Adds Bold Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials11 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- BOLD-100 ± FOLFOX ± Bevacizumab Chemotherapy (Arm VII)Phase 2 · Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
- BOLD-100 in combination with FOLFOX Chemotherapy (Arms I-VI)Phase 2 · Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- BOLD-100 in Combination With FOLFOX With or Without Bevacizumab for the Treatment of Advanced, Solid TumoursPHASE1_PHASE2 · RECRUITING · started Aug 28, 2020ClinicalTrials.gov NCT04421820 · fetched Nov 12, 2026